Skip to Main Content

Despite being the most common form of inflammatory arthritis, gout is often not treated with the urgency that reflects the serious impact the disease has on patients or its chronic and systemic nature. Dr. Brian LaMoreaux, rheumatologist and a medical director at Horizon, discusses how recent data suggests employing immunomodulation may help to optimize treatment outcomes among people living with uncontrolled gout. Click here to read more.